CENTENE CORP DEL's ticker is CNC and the CUSIP is 15135B101. A total of 832 filers reported holding CENTENE CORP DEL in Q2 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Politan Capital Management LP | 12,914,408 | $1,092,688,000 | 100.00% |
| VeriStar Capital Management LP | 122,932 | $10,401,000 | 9.53% |
| Pavadi Capital LLC | 106,108 | $8,978,000 | 8.14% |
| Integral Health Asset Management, LLC | 350,000 | $29,614,000 | 6.09% |
| BRIDGER MANAGEMENT, LLC | 318,300 | $26,931,000 | 6.07% |
| Vantage Investment Partners, LLC | 857,313 | $72,537,000 | 5.79% |
| SCHARF INVESTMENTS, LLC | 1,982,341 | $167,726,000 | 5.72% |
| HealthCor Management, L.P. | 540,860 | $45,762,000 | 4.60% |
| Stanley Capital Management, LLC | 164,800 | $13,944,000 | 4.44% |
| Sio Capital Management, LLC | 129,011 | $10,916,000 | 4.10% |
| LYRICAL ASSET MANAGEMENT LP | 2,734,093 | $231,332,000 | 4.02% |
| Sustainable Insight Capital Management, LLC | 41,900 | $3,854,000 | 3.84% |
| Alamar Capital Management, LLC | 40,083 | $3,391,000 | 3.83% |
| Sivik Global Healthcare LLC | 75,000 | $6,346,000 | 3.61% |
| PFM Health Sciences, LP | 1,112,480 | $94,127,000 | 3.59% |
| Westbourne Investment Advisors, Inc. | 66,150 | $5,597,000 | 3.47% |
| SECTOR GAMMA AS | 181,799 | $15,382,000 | 3.44% |
| VIKING GLOBAL INVESTORS LP | 8,293,867 | $701,744,000 | 3.21% |
| CORTLAND ASSOCIATES INC/MO | 226,682 | $19,180,000 | 3.17% |
| HOMESTEAD ADVISERS CORP | 1,270,973 | $107,537,000 | 3.04% |
About CENTENE CORP DEL
Centene Corp Del is a healthcare company that provides a range of services to individuals and families who are eligible for government-sponsored healthcare programs. The company operates in 32 states in the United States and has a strong presence in the Medicaid and Medicare markets.
Centene Corp Del has a diverse portfolio of products and services, including health plans, specialty services, and managed care solutions. The company's health plans cover a wide range of medical services, including primary care, specialty care, and prescription drugs. Its specialty services include behavioral health, dental, and vision care, while its managed care solutions help to improve the quality and efficiency of healthcare delivery.
The company has a strong leadership team, including Michael F. Neidorff, the Chairman, President, and CEO, who has been with the company since 1996. Under his leadership, Centene Corp Del has grown to become one of the largest healthcare companies in the United States.
Centene Corp Del has a strong commitment to social responsibility and has implemented a number of initiatives to improve the health and well-being of the communities it serves. The company has also been recognized for its efforts to promote diversity and inclusion in the workplace.
Overall, Centene Corp Del is a well-established healthcare company with a strong track record of growth and innovation. Its diverse portfolio of products and services, strong leadership team, and commitment to social responsibility make it a compelling investment opportunity for stock market investors.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists CENTENE CORP DEL's shareholders in Q2 2022. To view CENTENE CORP DEL's shareholder history, click here.